Aeterna Zentaris Inc, A Biopharma Stock, Popped After Update
Sean Mason, SmallCapPower.com | Jul 20, 2017 02:16AM ET
An update from the U.S. Food and Drug Administration was sweet medicine for investors in a biopharma stock Wednesday. Here’s some small stocks making big moves on Wednesday, July 19, 2017 (as of 4 pm EST):
Aeterna Zentaris Inc (TO:AEZS), a biopharma stock, surged 126% to $2.94 on Wednesday after announcing that it has been notified by the U.S. Food and Drug Administration (FDA) that its New Drug Application seeking approval of Macrilen for the evaluation of growth hormone deficiency in adults has been accepted as a complete response to the FDA’s November 5, 2014 Complete Response Letter and granted a PDUFA date of December 30, 2017.
As well, shares of Wavefront Technology Solutions Inc (OTC:WFTSF) climbed 29% to $0.155 as the provider of fluid injection technology for oil and gas well stimulation and Improved/Enhanced oil recovery said its strategic marketing partner Gulf Drilling and Maintenance Company believes that Wavefront’s Powerwave will shortly become the reservoir stimulation method of choice in Kuwait.
Ashburton Ventures Inc (V:ABR), meanwhile, reported that BC Bud Depot’s Research and Development facility on Salt Spring Island has placed an initial 20-ton zeolite order based on what the Company called the “encouraging results” of an ongoing study into the effects of Ashburton’s Z-1 Zeolite and ZMM T-Carbon on cannabis growth and productivity. Ashburton Ventures stock moved up as much as 13% before ending unchanged at $0.155.
Finally, Osisko Mining Corp (TO:OSK) shares rose 7% to $4.31 after the gold junior announced new results from the ongoing drill program at its 100% owned Windfall Lake gold project in Québec, which included 24.9 g/t gold over 31.0 metres.
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.